Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report)’s stock price hit a new 52-week low during trading on Monday after JPMorgan Chase & Co. lowered their price target on the stock from $550.00 to $450.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Intuitive Surgical traded as low as $342.10 and last traded at $346.0910, with a volume of 1394898 shares changing hands. The stock had previously closed at $345.42.
A number of other research firms also recently weighed in on ISRG. Royal Bank Of Canada decreased their price target on Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a research note on Monday, July 13th. Wells Fargo & Company reissued an “overweight” rating and issued a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a report on Friday. Piper Sandler restated an “overweight” rating and set a $470.00 target price (down from $580.00) on shares of Intuitive Surgical in a research report on Friday. Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Finally, BTIG Research reduced their price objective on shares of Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating for the company in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $523.46.
Check Out Our Latest Research Report on Intuitive Surgical
Insider Buying and Selling
Hedge Funds Weigh In On Intuitive Surgical
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. Norges Bank acquired a new stake in Intuitive Surgical during the fourth quarter worth about $2,856,987,000. J. Stern & Co. LLP raised its holdings in shares of Intuitive Surgical by 18,504.6% in the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock worth $1,204,788,000 after purchasing an additional 2,115,814 shares during the period. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Intuitive Surgical by 1,043.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock valued at $760,124,000 after purchasing an additional 1,224,734 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares in the last quarter. Finally, Polen Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth about $477,225,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Intuitive Surgical Stock Performance
The stock has a fifty day moving average price of $415.28 and a 200-day moving average price of $467.12. The firm has a market cap of $122.12 billion, a PE ratio of 39.53, a PEG ratio of 2.80 and a beta of 1.46.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 17.09%. Intuitive Surgical’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.81 earnings per share. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 8.62 earnings per share for the current fiscal year.
Intuitive Surgical Company Profile
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- 3 Nuclear Stocks for Investors Willing to Wait Out the Dip
- 3 Medical Device Stocks Giving Investors a Different Healthcare Play
- Cybersecurity Stocks Are Holding Up as the AI Trade Starts to Crack
- Bank Earnings Are Roaring, But Wall Street Isn’t Ready to Celebrate
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
